SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* WEIL JOHN D (Last) (First) (Middle) 200 N BROADWAY SUITE 825 (Street) ST LOUIS MO 63102 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol ALLIED HEALTHCARE PRODUCTS INC [ AHPI ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director X 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 08/20/2018
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/20/2018		J		36,936.5(1)	A	$0	90,513.5	D
Common Stock								2,500	I	IRA
Common Stock								94,427(2)	I	Spouse
Common Stock								59,101(3)	I	Trust
Common Stock								7,927(5)	I	Corporation
Common Stock								119,792(6)	I	Trust
Common Stock	08/20/2018		J		357,304(4)	D	$0	137,735(8)	I	Limited Partnership

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)	$4.05							11/13/2009(7)	11/13/2018	Common Stock	1,500		1,500	D
Option (right to buy)	$5.04							11/13/2010	11/13/2019(7)	Common Stock	1,500		1,500	D
Option (right to buy)	$4.34							11/11/2011(7)	11/11/2020	Common Stock	1,500		1,500	D
Option (right to buy)	$3.555							11/10/2012(7)	11/10/2021	Common Stock	1,500		1,500	D
Option (right to buy)	$2.59							11/08/2013(7)	11/08/2022	Common Stock	1,500		1,500	D
Option (right to buy)	$2.31							11/14/2014(7)	11/14/2023	Common Stock	1,500		1,500	D
Option (right to buy)	$1.58							11/13/2015(7)	11/13/2024	Common Stock	1,500		1,500	D
Option (right to buy)	$1.17							11/12/2016(7)	11/12/2025	Common Stock	1,500		1,500	D
Option (right to buy)	$1.13							11/10/2017(7)	11/10/2026	Common Stock	1,500		1,500	D
Option (right to buy)	$2.22							11/09/2018(7)	11/09/2027	Common Stock	750		750	D

Explanation of Responses:

1. Shares acquired in a transfer for no consideration from a family limited partnership, as reported on this Form 4 in the last line item of this Table 1, which transaction is exempt from Section 16 pursuant to Rule 16a-13.

2. The reporting person disclaims any economic benefit in such shares.

3. Owned by a trust for the benefit of the reporting person and for which the reporting person acts as co-trustee.

4. Shares disposed of in a transfer for no consideration from a family limited partnership to the reporting person and members of the reporting person's family, in a transaction exempt from Section 16 pursuant to Rule 16a-13, including the transfer of 36,963.50 shares to the reporting person's direct ownership as reported on this Form 4 in the first line item of the Table 1.

5. Owned by a corporation controlled by the reporting person.

6. Owned by trusts for which the reporting person acts as co-trustee and with respect to which the reporting person disclaims any economic benefit in such shares.

7. Options may not be exercised for a period of one year from the date of the grant and thereafter are exercisable in full.

8. Owned by a family limited partnership of which the reporting person acts as one of several general partners. Number of shares includes all shares held by limited partnership. The reporting person disclaims beneficial ownership of shares held by the limited partnership in excess of the reporting person's proportionate interest as determined pursuant to Rule 16a-1(2)(ii)(B)

	John D. Weil	08/21/2018
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.